Inventor · disambiguated record
Kenji Kadomatsu
Also filed as: KADOMATSU KENJI
10 granted patents·9 pending applications·46 citations·filing 1998–2013
84Inventor score
Files withUNIV NAGOYA NAT UNIV CORP5HORIBA MITSURU3SEIKAGAKU KOGYO CO LTD3KADOMATSU KENJI2TAKASHI MURAMATSU2
Top patents by PatentIndex Score
19 records- 0173US8288343B2Activation of endothelial nitric oxide synthase by midkine and uses therefor in effecting vasodilationHORIBA MITSURU·Filed 2008·Granted Oct 16, 2012·8 cites·7 claims
- 0267US6572851B2Method for suppressing or treating drug-induced nephropathyTAKASHI MURAMATSU·Filed 1998·Granted Jun 3, 2003·27 cites·4 claims
- 0361US2011275137A1Improving agent for neuropathic painSEIKAGAKU KOGYO CO LTD·Filed 2009·Application pending·0 cites
- 0460US6037159APolypeptide of N-acetylglucosamine-6-O-sulfotransferase and DNA encoding the sameSEIKAGAKU KOGYO CO LTD·Filed 1999·Granted Mar 14, 2000·11 cites·13 claims
- 0558US2003008366A1Polypeptide of N-acetylglucosamine-6-O-sulfotransferase and DNA encoding the sameFiled 2002·Application pending·0 cites
- 0655US9592279B2Agent for neuropathic painNAT UNIV CORP NAGOYA UNIV·Filed 2013·Granted Mar 14, 2017·0 cites·12 claims
- 0752US9840552B2Monoclonal antibody against human midkineUNIV NAGOYA NAT UNIV CORP·Filed 2013·Granted Dec 12, 2017·0 cites·6 claims
- 0851US7820160B2Midkine inhibitory compositions for the treatment of angiostenosisMEDICAL THERAPIES LTD·Filed 2007·Granted Oct 26, 2010·0 cites·9 claims
- 0950US7309695B2Pharmaceutical compositions for the prevention and treatment of atherosclerosis and restenosis after PTCATAKASHI MURAMATSU·Filed 2003·Granted Dec 18, 2007·0 cites·4 claims
- 1050US2005079151A1Therapeutic agents for apoptosis-related diseasesFiled 2003·Application pending·0 cites
- 1149US2011059508A1Improving agent for dysfunction due to neuropathy and rho kinase activation inhibitorUNIV NAGOYA NAT UNIV CORP·Filed 2008·Application pending·0 cites
- 1248US8754036B2Method for treating neuropathic painUNIV NAGOYA NAT UNIV CORP·Filed 2013·Granted Jun 17, 2014·0 cites·5 claims
- 1348US2009047319A1Pharmaceutical composition for obstructive vascular diseaseKADOMATSU KENJI·Filed 2006·Application pending·0 cites
- 1448US2011059102A1Therapeutic Method Targeting MidkineUNIV NAGOYA NAT UNIV CORP·Filed 2009·Application pending·0 cites
- 1546US2011111427A1Biomarker for the estimation of acute renal disorder and prognosis of the disorder, and use of the biomarkerKADOMATSU KENJI·Filed 2009·Application pending·0 cites
- 1644US9023799B2Method to reduce loss of cardiac function following ischemia/reperfusionHORIBA MITSURU·Filed 2005·Granted May 5, 2015·0 cites·7 claims
- 1739US2011125075A1Method for control of electroporation apparatusUNIV NAGOYA NAT UNIV CORP·Filed 2006·Application pending·0 cites
- 1839US2010105613A1Therapeutic agent for occlusive peripheral vascular disease, and use thereofHORIBA MITSURU·Filed 2007·Application pending·0 cites
- 1933US6455289B1Polypeptide of N-acetylglucosamine-6-O-sulfotransferase and DNA encoding the sameSEIKAGAKU KOGYO CO LTD·Filed 1999·Granted Sep 24, 2002·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Kenji Kadomatsu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →